SUMMARY The mannitol-lactulose intestinal permeability test was evaluated in 100 healthy controls and 47 patients with Crohn's disease. These patients were further separated into three subgroups of increased activity (Harvey-Bradshaw index) and in two subgroups, with elective colonic lesions and associated ileal and colonic lesions. Results were given as percentages of urinary recoveries for mannitol (M), lactulose (L), and L/M ratio. As a whole, patients with Crohn's disease have lower mean M and higher mean L and mean L/M ratios than controls. The magnitude of alterations in M, L, and L/M increased with activity. The sensitivity of the test, however, reached interesting figures (67% :L and 86%:L/M) only in subgroup III which was composed of relapsing patients. Mean M was lower in patients with associated ileal lesion but, whatever the criterion (M, L, or L/M), the test does not provide any clue for the detection of a possible infraclinical associated ileal localisation.
Since the introduction of simple and reliable tests, modifications in intestinal permeability have been observed in various diseases such as untreated coeliac disease, '- dermatitis herpetiformis,' atopic eczema,3 digestive allergy,'' and during different types of chimiotherapy. 4 The existence itself or the magnitude of these modifications have sometimes been questioned however; in treated coeliac disease for example.' h Several investigators, using various probes of intermediate (MW 150-400) molecular size ("Cr EDTA, PEG 400, lactulose, mannitol, rhamnose), have reported either a lesser' or a greater`" intestinal permeability in patients with Crohn's disease and their healthy relatives.'2 These discrepancies can be partly explained by large interindividual variations even in healthy subjects and by the relatively small size of the investigated populations.
The aim of the present study was to examine the nature, the prevalence and the magnitude of such modifications by testing large groups of healthy people and patients with Crohn's disease of various activities and different localisations. For the sake of safety and simplicity, lactulose and mannitol, used simultaneously in a combined test, were chosen as probes for unmediated nm3: mannitol and 362x 10-2 nm3: lactulose), is supposed to allow a differential estimation of transcellular pathways through small size channels, and paracellular pathways through large size channels.`9 16 Furthermore, the simultaneous use group.bmj.com on June 2, 2017 -Published by http://gut.bmj.com/ Downloaded from of these two sugars and the calculation of L/M makes the test independent of the degree of completion of the urine collection. Finally, it is known that intestinal permeability to mannitol is close to that of rhamnose'6 and permeability to lactulose does not differ from that of EDTA 5Cr, and the temporal pattern of absorption of these three markers has been recently described."7 This second point suggests that, at last in healthy subjects, errors caused by microbial catabolism of the sugar test are unlikely. '5 Several experiments either with 5Cr EDTA given orally7'8 and rectally'" or sugars""9'" have already shown modifications in intestinal permeability. 
